Barrett's esophagus: proton pump inhibitors and chemoprevention I. - Wikidata - awgldk - TriplyDB

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

http://www.wikidata.org/entity/Q37939281

about

Questionnaire-based survey conducted in 2011 concerning endoscopic management of Barrett's esophagus in East Asian countries.

P2860

Q34356804-2A727CB8-1BEC-4CE0-9285-6DEDB316059A

P2860

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

http://www.wikidata.org/entity/Q37939281

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

@en

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

@nl

type

label

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

@en

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

@nl

prefLabel

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

@en

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

@nl

P1433

Q37939281-5AAF53AA-0397-4424-A905-45A2928D357D

P1476

Q37939281-6768ED31-4762-4874-9775-561A42099993

P2093

Q37939281-0CAD8C58-290E-4A77-BFB7-1E893486EEBF

Q37939281-1088022A-F85F-4F68-AF99-2000E9D61452

Q37939281-11CE2C44-4A1B-408A-83A3-D57BB09ACE11

Q37939281-179E3917-823B-4202-97EE-E7538840C94F

Q37939281-17DA96A8-193B-46B5-9B8B-72E3A4745197

Q37939281-2FB2CE46-B861-4123-B8A6-C33DEF7DC0EF

Q37939281-48827312-78E3-4D7B-96B5-DEED7F12B604

Q37939281-4AF492E4-DBC9-443F-A919-599C70E32E39

Q37939281-5A36683A-9340-43B5-817A-C216CD9D9AC2

Q37939281-613F58D2-CE7E-4D7A-8DC8-75191835028C

P2860

Q37939281-05133521-4FE5-4FE2-B633-72EC389370CA

Q37939281-0794F05B-8C1B-4D19-BF3E-493866E15E3A

Q37939281-08D062A0-410C-4570-B2BD-400B17153032

Q37939281-097D671A-0051-4661-8097-E89D5DDCF79C

Q37939281-11B911CD-AF66-41C8-86B2-28CC5B2A94F3

Q37939281-21FC62F8-D777-4533-9AC0-1EE3F6DB8449

Q37939281-222072C6-9626-453A-AE34-6BFFBF8AFA5D

Q37939281-2328E1AB-D25A-4298-A16A-7405CC1A95A3

Q37939281-29C2C6C8-4B20-44EB-98EF-D2A0B05398AD

Q37939281-2F87A5FF-606F-4B74-A36C-02ACFA73BB3A

P304

Q37939281-05B8F3F6-BBE0-4162-AB86-BF912B4EAC7A

P31

Q37939281-0E1EBF84-5BDB-4BDF-B960-7886B4547603

P356

Q37939281-931D0644-58B1-4E9B-BFFA-B464ECF11DC7

P407

Q37939281-1B35DAD3-22CF-4F5B-B515-6658B020F6F3

P478

Q37939281-4CD546CD-01B0-416F-A49F-F05296C9B736

P50

Q37939281-80A950DC-CD2F-47AB-BF99-B2CDCACF3AA9

Q37939281-904846D7-3551-469F-AEEF-35E3859661E6

P577

Q37939281-16FAE899-03FA-4359-9F3F-4628AE712BA4

P698

Q37939281-455D7E41-F26B-4CC3-9C0E-87968ECF8498

P356

J.1749-6632.2011.06047.X

P1433

Annals of the New York Academy of Sciences

P1476

Barrett's esophagus: proton pump inhibitors and chemoprevention I

@en

P2093

Aaron Goldman

http://www.w3.org/2001/XMLSchema#string

Cord Langner

http://www.w3.org/2001/XMLSchema#string

Daniel Sifrim

http://www.w3.org/2001/XMLSchema#string

Duccio Rossi Degli'Innocenti

http://www.w3.org/2001/XMLSchema#string

Emmanuella Masini

http://www.w3.org/2001/XMLSchema#string

Francesca Castiglione

http://www.w3.org/2001/XMLSchema#string

George Triadafilopoulos

http://www.w3.org/2001/XMLSchema#string

Giancarlo Freschi

http://www.w3.org/2001/XMLSchema#string

Grzegorz Wallner

http://www.w3.org/2001/XMLSchema#string

Helmut Neumann

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects.

Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease.

Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus"

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.

Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.

Pathophysiology and treatment of Barrett's esophagus.

Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S.

Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.

Occurrence and significance of gastric colonization during acid-inhibitory therapy.

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.

P304

93-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2011.06047.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

1232

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21950809

http://www.w3.org/2001/XMLSchema#string